Aemetis

Company AMTX

Last mentioned: 3d ago

Timeline

  1. Lorundrostat PDUFA Date

    Target date for FDA decision on Mineralys' lead product candidate.

  2. Nektar Phase 3 Launch

    Nektar plans first patient randomization for its Atopic Dermatitis program.

  3. Mineralys NDA Acceptance

    FDA accepts Mineralys' NDA for lorundrostat for uncontrolled hypertension.

  4. EHang Record Deliveries

    EHang closes Q4 with 100 eVTOL units delivered and first GAAP profit.

  5. HeartBeam FDA Clearance

    HeartBeam secures 510(k) clearance for 12-lead ECG synthesis software.

Stories mentioning Aemetis 1

Aerospace Bullish

EHang Hits Profitability Milestone as eVTOL and AR Sectors Scale for 2026

EHang (EH) achieved its first quarterly GAAP profit on record eVTOL deliveries, signaling a commercial inflection point for Advanced Air Mobility. Simultaneously, Vuzix (VUZI) reported a 76% revenue surge in smart glasses and waveguide technology, underscoring robust demand for dual-use augmented reality systems.

15 sources